Predicting bone marrow suppression from urinal 8-hydroxy-2'-deoxyguanosine level during the treatment with radium-223 in patients with cancer bone metastasis
These results suggest that a urinal 8-OHdG concentration has a potency of biomarker for bone marrow suppression under the administration of radium-223 in the patient with BM from CRPC.
Authors
- Satoru Monzen (ORCID: https://orcid.org/0000-0003-2436-8048)
- Keito Suto (ORCID: https://orcid.org/0000-0001-8212-5664)
- Andrzej Wójcik (ORCID: https://orcid.org/0000-0002-3951-774X)
- Kenji Terada
- Yuki Kasai (ORCID: https://orcid.org/0000-0003-3451-0124)
- Yuki Morino (ORCID: https://orcid.org/0000-0003-1241-4131)
- Yasushi Mariya
- Ryota Kinbara
Institutions
- Hirosaki University (JP)
- Stockholm University (SE)
- Aomori Rosai Hospital (JP)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.21037/tcr-24-812
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00